Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|September 21, 2022
Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromesJohanne Rozema, Ivar van Asten, Beau Kwant, et al.
Hematological Oncology|October 31, 2017
Relapse in stage I(E) diffuse large B-cell lymphomaMarcel Nijland, Karin Boslooper, Gustaaf van Imhoff, et al.
Parkinsonism & Related Disorders|December 26, 2016
New insights in the neurological phenotype of aceruloplasminemia in Caucasian patientsLena H P Vroegindeweij, Janneke G Langendonk, Mirjam Langeveld, et al.
Leukemia & Lymphoma|November 12, 2022
Adherence to quality indicators in chronic myeloid leukemia care: results from a population-based study in The NetherlandsGeneviève I C G Ector, Inge G P Geelen, Avinash G Dinmohamed, et al.
Ejhaem|September 2, 2022
Increased prescription rate of anti-infective agents after diagnosis of myelodysplastic syndromesJohanne Rozema, Mels Hoogendoorn, Iris Potma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Early detection and rapid isolation of leukemia-reactive donor T cells for adoptive transfer using the IFN-gamma secretion assayInge Jedema, Pauline Meij, Esther Steeneveld, et al.
Haematologica|September 2, 2017
Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemiaInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
European Journal of Haematology|December 31, 2017
Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safeInge G P Geelen, Noortje Thielen, Jeroen J W M Janssen, et al.
British Journal of Haematology|September 9, 2016
Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern NetherlandsEsther G M de Waal, Marnix Leene, Nic Veeger, et al.
Bone|February 26, 2020
No decrease in fracture risk despite 15 years of treatment evolution for multiple myeloma patients: A Danish nationwide case-control studyBerdien E Oortgiesen, Johanna H M Driessen, Mels Hoogendoorn, et al.
Pageof 7